Concepedia

Gongyan Chen

GC

4

Publications

3.3K

Citations

4

H-Index

2019

Active since

Affiliations

Peking University Cancer Hospital(Current)

Anhui Medical University

Peking University

Fujian Provincial Cancer Hospital

Linyi People's Hospital

Gongyan Chen is an author at Peking University Cancer Hospital specializing in clinical trials, pharmacotherapy, and cancer therapeutics.

Top concepts

Publications per year

2019–2024

4

Publications

4

Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial

Tony Mok, Yi‐Long Wu, Iveta Kudaba et al. · The Lancet · 2019 · 3.2K citations · Full text

Camrelizumab Plus Carboplatin and Pemetrexed as First-Line Treatment for Advanced Nonsquamous NSCLC: Extended Follow-Up of CameL Phase 3 Trial

Caicun Zhou, Gongyan Chen, Yunchao Huang et al. · Journal of Thoracic Oncology · 2023 · 65 citations · Full text

, , +9

Efficacy and Safety of Limertinib (ASK120067) in Patients With Locally Advanced or Metastatic EGFR Thr790Met-Mutated NSCLC: A Multicenter, Single-Arm, Phase 2b Study

Yuankai Shi, Baolan Li, Lin Wu et al. · Journal of Thoracic Oncology · 2022 · 25 citations · Full text

Camrelizumab plus carboplatin and pemetrexed as first-line therapy for advanced non-squamous non-small-cell lung cancer: 5-year outcomes of the CameL randomized phase 3 study

Caicun Zhou, Gongyan Chen, Yunchao Huang et al. · Journal for ImmunoTherapy of Cancer · 2024 · 16 citations · Full text

Rows per page

1–4 of 4